AU2447097A - Oral coated active drugs - Google Patents

Oral coated active drugs

Info

Publication number
AU2447097A
AU2447097A AU24470/97A AU2447097A AU2447097A AU 2447097 A AU2447097 A AU 2447097A AU 24470/97 A AU24470/97 A AU 24470/97A AU 2447097 A AU2447097 A AU 2447097A AU 2447097 A AU2447097 A AU 2447097A
Authority
AU
Australia
Prior art keywords
active drugs
coated active
oral
oral coated
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24470/97A
Inventor
Mandana Asgharnejad
Colin R. Gardner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9608929.7A external-priority patent/GB9608929D0/en
Priority claimed from GBGB9619063.2A external-priority patent/GB9619063D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2447097A publication Critical patent/AU2447097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU24470/97A 1996-04-10 1997-04-07 Oral coated active drugs Abandoned AU2447097A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US1517696P 1996-04-10 1996-04-10
US60015176 1996-04-10
GB9608929 1996-04-29
GBGB9608929.7A GB9608929D0 (en) 1996-04-29 1996-04-29 Oral coated firbrinogen receptor antagonist composition
US2399996P 1996-08-12 1996-08-12
US60023999 1996-08-12
GB9619063 1996-09-12
GBGB9619063.2A GB9619063D0 (en) 1996-09-12 1996-09-12 Oral coated active drugs
PCT/US1997/005800 WO1997037641A1 (en) 1996-04-10 1997-04-07 Oral coated active drugs

Publications (1)

Publication Number Publication Date
AU2447097A true AU2447097A (en) 1997-10-29

Family

ID=27451442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24470/97A Abandoned AU2447097A (en) 1996-04-10 1997-04-07 Oral coated active drugs

Country Status (5)

Country Link
EP (1) EP0914099A1 (en)
JP (1) JPH11510514A (en)
AU (1) AU2447097A (en)
CA (1) CA2251022A1 (en)
WO (1) WO1997037641A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
KR20040076203A (en) * 2003-02-24 2004-08-31 주식회사 엘지생명과학 Orally administrable pharmaceutical compositions and methods for preventing food-drug interaction
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374430A (en) * 1986-09-18 1994-12-20 London School Of Pharmacy Pharmaceutical formulation
US5446056A (en) * 1993-11-24 1995-08-29 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists

Also Published As

Publication number Publication date
JPH11510514A (en) 1999-09-14
WO1997037641A1 (en) 1997-10-16
CA2251022A1 (en) 1997-10-16
EP0914099A1 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
AU7375598A (en) Stable oral pharmaceutical dosage forms
AU5428096A (en) Oral 2-methyl-thieno-benzodiazepine formulation
AU7572196A (en) Pharmaceutical formulations
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
AU6995396A (en) Pharmaceutical formulation
AU4892897A (en) Phospholipid drug derivatives
AU6456996A (en) Polymeric drug formulations
AU4477597A (en) New pharmaceutically active compounds
AU5387898A (en) Pharmaceutical agents
AU6973396A (en) Pharmaceutical formulation
AU7590096A (en) Drug composition
AU1827799A (en) Oral delivery formulation
AU7964398A (en) Dental formulation
AU1409100A (en) Drugs
AU5838398A (en) Rapamycin formulations for oral administration
AU3888597A (en) Oral contraceptive
AU2080199A (en) New pharmaceutically active compounds
AU5401796A (en) Solid delivery form for oral use
AU7582696A (en) Pharmaceutical formulation
AU5347996A (en) Preparation for oral administration
AU4143397A (en) New pharmaceutically active compounds
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU7000496A (en) Anti-inflammatory antisense drug
AU2447097A (en) Oral coated active drugs